Enova International, Inc.
ENVA NYSE Personal Credit Institutions Financials FY2016βFY2025
What Enova International, Inc. does
No business description yet.
- Legal name
- Enova International, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 20, 2026
- Accession Β· CIK
- 0001193125-26-060461
0001529864
Revenue and margins
Enova International, Inc. had $3.2B of revenue in fiscal 2025, up 18.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 30.8% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.8B in fiscal 2025, 56.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Enova International, Inc. returned $215M to shareholders in fiscal 2025, 12% of free cash flow. The diluted share count fell 5.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Enova International, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $165M | $100M | $54.4M | $73.9M | $71.7M |
| Debt incl. finance leases | $1.4B | $2.3B | $2.9B | $3.6B | $4.5B |
| Net debt / EBITDA | 2.7x | 5.1x | 6.3x | 5.6x | 5.7x |
| Debt / equity | 1.3x | 1.9x | 2.4x | 3.0x | 3.4x |
| Interest coverage | 5.4x | 3.3x | 2.2x | 2.0x | 2.2x |
| Total assets | $2.8B | $3.8B | $4.6B | $5.3B | $6.5B |
| Total liabilities | $1.7B | $2.6B | $3.3B | $4.1B | $5.1B |
| Shareholders' equity | $1.1B | $1.2B | $1.2B | $1.2B | $1.3B |
| Net debt (β = net cash) | $1.2B | $2.2B | $2.9B | $3.5B | $4.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 8 | 6 / 8 | 7 / 8 | 7 / 8 | 4 / 8 | 5 / 8 | 5 / 8 | 6 / 8 | 6 / 8 |
| Accruals ratio | β36.7% | β39.1% | β49.3% | β55.8% | β19.7% | β8.9% | β21.0% | β23.7% | β27.0% | β25.7% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $746M | $729M | $973M | $1.2B | $1.1B | $1.2B | $1.7B | $2.1B | $2.7B | $3.2B |
| Net interest income | β$65.6M | β$74.0M | β$79.4M | β$75.6M | β | β | β | β | β | β |
| Gross profit | $418M | $375M | $469M | $572M | $684M | $1.0B | $1.1B | $1.2B | $1.5B | $1.8B |
| Operating income | $121M | $116M | $176M | $248M | $358M | $413M | $384M | $422M | $585M | $739M |
| Interest expense | β | β | $79.4M | $75.6M | $86.7M | $76.5M | $116M | $195M | $290M | $339M |
| Pretax income | $57.4M | $19.7M | $68.9M | $170M | $435M | $337M | $273M | $227M | $271M | $401M |
| Income tax | $22.8M | $2.1M | $5.3M | $42.1M | $57.2M | $80.1M | $65.2M | $52.1M | $61.7M | $92.6M |
| Net income | $34.6M | $29.2M | $70.1M | $36.6M | $378M | $256M | $207M | $175M | $209M | $308M |
| Diluted EPS | $1.03 | $0.86 | $1.99 | $1.06 | $11.70 | $6.79 | $6.19 | $5.49 | $7.43 | $11.52 |
| Diluted shares | 0.03B | 0.03B | 0.04B | 0.03B | 0.03B | 0.04B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $393M | $447M | $685M | $849M | $741M | $472M | $894M | $1.2B | $1.5B | $1.8B |
| Capital expenditure | $14.4M | $15.2M | $14.7M | $20.1M | $29.5M | $29.7M | $43.6M | $45.2M | $43.4M | $47.1M |
| Free cash flow | $379M | $432M | $670M | $829M | $711M | $442M | $850M | $1.1B | $1.5B | $1.8B |
| Depreciation and amortization | $15.6M | $13.3M | $14.2M | $15.1M | $19.7M | $35.4M | $36.9M | $38.2M | $40.2M | $41.8M |
| Stock-based compensation | $8.5M | $11.3M | $11.7M | $12.0M | $18.0M | $21.2M | $22.0M | $26.7M | $31.8M | $33.1M |
| Acquisitions | β | β | β | β | β$110M | $29.2M | β | β | β | β |
| Share buybacks | $0.4M | $5.1M | $17.3M | $33.8M | $56.4M | $117M | $143M | $153M | $289M | $215M |
| Dividends and buybacks | $0.4M | $5.1M | $17.3M | $33.8M | $56.4M | $117M | $143M | $153M | $289M | $215M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $39.9M | $49.8M | $28.1M | $35.9M | $297M | $165M | $100M | $54.4M | $73.9M | $71.7M |
| Total debt | $650M | $789M | $858M | $991M | $946M | $1.4B | $2.3B | $2.9B | $3.6B | $4.5B |
| Loans, net | $562M | $705M | $780M | $1.1B | β | β | β | β | β | β |
| Property and equipment, net | $47.1M | $48.5M | $46.1M | $54.5M | $79.4M | $78.4M | $93.2M | $109M | $120M | $133M |
| Goodwill | $267M | $267M | $267M | $267M | $268M | $279M | $279M | $279M | $279M | $279M |
| Intangible assets | $5.4M | $4.3M | $3.3M | $2.2M | $26.0M | $35.4M | $27.4M | $19.0M | $11.0M | $3.7M |
| Total assets | $978M | $1.2B | $1.3B | $1.6B | $2.1B | $2.8B | $3.8B | $4.6B | $5.3B | $6.5B |
| Total liabilities | $736M | $878M | $987M | $1.2B | $1.2B | $1.7B | $2.6B | $3.3B | $4.1B | $5.1B |
| Preferred stock | β | β | β | β | β | β | β | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $242M | $282M | $348M | $377M | $917M | $1.1B | $1.2B | $1.2B | $1.2B | $1.3B |
| Margins | ||||||||||
| Gross margin | 56.0% | 51.5% | 48.2% | 48.7% | 63.1% | 84.8% | 64.4% | 58.1% | 57.5% | 58.1% |
| Operating margin | 16.3% | 15.9% | 18.0% | 21.1% | 33.0% | 34.2% | 22.1% | 19.9% | 22.0% | 23.5% |
| EBITDA margin | 18.4% | 17.8% | 19.5% | 22.4% | 34.8% | 37.1% | 24.2% | 21.7% | 23.5% | 24.8% |
| Net margin | 4.6% | 4.0% | 7.2% | 3.1% | 34.9% | 21.2% | 11.9% | 8.3% | 7.9% | 9.8% |
| FCF margin | 50.8% | 59.3% | 68.9% | 70.5% | 65.6% | 36.6% | 49.0% | 53.0% | 56.3% | 56.2% |
| Net interest share of revenue | β8.8% | β10.2% | β8.2% | β6.4% | β | β | β | β | β | β |
| Returns | ||||||||||
| Return on capital | 9.3% | 10.2% | 13.8% | 14.0% | 19.8% | 13.6% | 8.7% | 7.9% | 9.6% | 9.9% |
| Return on equity | 14.3% | 11.2% | 22.3% | 10.1% | 58.4% | 25.5% | 18.2% | 14.4% | 17.2% | 24.3% |
| Return on assets | 3.5% | 2.7% | 5.6% | 2.5% | 20.5% | 10.5% | 6.3% | 4.2% | 4.3% | 5.3% |
| Return on tangible equity | β | 282.6% | 90.4% | 34.1% | 60.6% | 32.9% | 23.6% | 18.6% | 23.1% | 29.3% |
| Growth | ||||||||||
| Revenue growth | β | β2.2% | 33.4% | 20.8% | β7.8% | 11.5% | 43.7% | 22.0% | 25.5% | 18.6% |
| Net income growth | β | β15.5% | 139.7% | β47.8% | 932.0% | β32.2% | β19.1% | β15.6% | 19.6% | 47.2% |
| EPS growth | β | β16.5% | 131.4% | β46.7% | 1,003.8% | β42.0% | β8.8% | β11.3% | 35.3% | 55.0% |
| FCF growth | β | 14.0% | 55.2% | 23.6% | β14.1% | β37.8% | 92.3% | 31.9% | 33.3% | 18.5% |
| Share count change | β | 2.0% | 3.1% | β2.2% | β6.1% | 16.8% | β11.3% | β4.7% | β11.7% | β5.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 4.5x | 5.7x | 4.4x | 3.6x | 1.7x | 2.7x | 5.1x | 6.3x | 5.6x | 5.7x |
| Debt / equity | 2.7x | 2.8x | 2.5x | 2.6x | 1.0x | 1.3x | 1.9x | 2.4x | 3.0x | 3.4x |
| Interest coverage | β | β | 2.2x | 3.3x | 4.1x | 5.4x | 3.3x | 2.2x | 2.0x | 2.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.9% | 2.1% | 1.5% | 1.7% | 2.7% | 2.5% | 2.5% | 2.1% | 1.6% | 1.5% |
| Stock comp / revenue | 1.1% | 1.6% | 1.2% | 1.0% | 1.7% | 1.8% | 1.3% | 1.3% | 1.2% | 1.1% |
| Payouts / FCF | 0.1% | 1.2% | 2.6% | 4.1% | 7.9% | 26.4% | 16.8% | 13.7% | 19.3% | 12.1% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 6.0 | 7.0 | 7.0 | 4.0 | 5.0 | 5.0 | 6.0 | 6.0 |
| Accruals ratio | β36.7% | β39.1% | β49.3% | β55.8% | β19.7% | β8.9% | β21.0% | β23.7% | β27.0% | β25.7% |
Source: SEC EDGAR XBRL filings (CIK 0001529864). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.